We have previously reported high-frequency microsatellite instability (MSI-H) and germ-line mismatch repair gene mutation in patients with unusually young onset of high-grade glioma. Some of these patients developed metachronous MSI-H colorectal cancer and conformed to the diagnosis of Turcot's syndrome. Frameshift mutation of TGFbRII was present in all the colorectal carcinomas but not in brain tumours. We further characterized the genetic pathways of tumour evolution in these metachronous gliomas and colorectal carcinomas. All MSI-H glioblastomas had inactivation of both alleles of the p53 gene and showed over-expression of the p53 protein while none of the colorectal carcinomas had p53 mutation or protein over-expression. Flow cytometry and comparative genomic hybridization revealed that all glioblastomas were chromosomal unstable with aneuploid DNA content, and with a variable number of chromosomal arm aberrations. In contrast, the colorectal carcinomas had diploid or near-diploid DNA content with few chromosomal arm aberrations. The pattern of chromosomal aberrations in the two organs was dierent. Loss of 9p was consistently observed in all glioblastomas but not in colorectal carcinomas. Epidermal growth factor receptor ampli®cation was absent in all glioblastomas and colorectal carcinomas. Our results suggest that both the frequency of p53 mutation and its eects dier greatly in the two organs. Following loss of mismatch repair function, p53 inactivation and chromosomal instability are not necessary for development of colorectal carcinoma, but are required for genesis of glioblastoma. Oncogene (2000) 19, 4079 ± 4083.
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We have previously reported high-frequency microsatellite instability (MSI-H) and germ-line mismatch repair gene mutation in four patients with unusually young onset of high-grade glioma (Leung et al., 1998) . Three of these patients also developed metachronous colorectal cancer and thus conform to the diagnosis of Turcot's syndrome. The colorectal carcinomas of these patients invariably showed high-frequency microsatellite instability and both gliomas and carcinomas showed loss of expression of the mismatch repair (MMR) protein corresponding to the germ-line mutation (Chan et al., 1999) . The evidence is therefore strong that all the tumours arose through clonal expansion of cells, in the colon or CNS, in which the residual normal MMR gene allele was silenced by a somatic event. Although the numbers of tumours are small, they aord a unique opportunity to study organspeci®c dierences in tumour evolution, within the same patient and arising from identical genetic backgrounds. In this short report we describe changes in the CNS and colorectal tumours in p53, DNA ploidy, gene ampli®cation aecting the epidermal growth factor receptor (EGFR) and, more generally, deletion and ampli®cation events occurring throughout the genome, as detected by comparative genomic hybridization (CGH). The data suggest that both the frequency of p53 mutation and its eects dier greatly in the two organs.
We analysed the tumour genomic DNA for p53 mutation in exons 5 to 9 by direct DNA sequencing (Table 1, Figure 1 ). In two of the MSI-H glioblastomas there is unequivocal evidence of inactivation of both alleles of the p53 gene. Patient C had mutation of CGC (Arg) to CAC (His) at codon 175. Patient A had mutation of CGT (Arg) to TGT (Cys) at codon 273. Both tumours had lost the wild-type alleles in the sequence tracing. Patient D had two mutations, including GGC (Gly) to AGC (Ser) at codon 245 and CGG (Arg) to TGG (Trp) at codon 282. We interpret this as indicative of independent, inactivating mutations involving both alleles of p53. Although we have no direct evidence against the theoretical possibility that the two mutations involved the same allele, it is dicult to envisage the selection pressure that might facilitate this otherwise extremely rare event. All mutations are of transition type, located at CpG sites which are mutational hotspots of the p53 gene. The mutations were con®rmed as somatic as they were absent in the germ-line DNA. These three glioblastomas also showed overexpression of the p53 protein by immunohistochemistry. Patient B had a mixed glioma with prominent oligodendroglial dierentiation, which did not overexpress p53. From this tumour, we were unable to recover DNA of sucient No mutation Near-Diploid 1pter-p36.1(7), 2q32(+), 12p127 hMLH1 + (1.08) q21(+), 13q21-q22(+), 22q (7) a These data were reported previously (Chan et al., 1999; Leung et al., 1998) . The patients' identi®cation is the same as Leung et al., 1998 . *p53 protein expression +++, strong nuclear staining in more than 70% tumour cells, 7, positive nuclear staining in only a few isolated tumour cells. GBM, glioblastoma; CRC, colorectal carcinoma
Figure 1 (a) Immunohistochemistry showed strong staining of most tumour cell nuclei in the glioblastoma but only in a few cells in the colorectal cancer of the Turcot's patient C. The p53 protein was detected in paran sections by the monoclonal antibody PAb1801 (Oncogene Science, dilution 1 : 100) using the standard streptavidin-biotin peroxidase method with microwave antigen retrieval (958C for 30 min in citrate buer pH 6.0). (b) Corresponding DNA histograms showed an aneuploid tumour with DNA index of 1.71 for the glioblastoma, and diploid for the colorectal cancer. The X-axis of the DNA histograms is red-¯uorescence corresponding to DNA content. Samples were prepared according to the method described (Hedley et al., 1983) and analysed by an EPICS XL-MCL¯ow cytometer (Beckman-Coulter). At least 10 000 nuclei were analysed in each sample. (c) DNA sequencing of the glioblastoma in patient C showed a G to A transition mutation in exon 5 codon 175, with loss of the wild-type allele. Direct genomic DNA sequencing of exon 5 ± 9 of the p53 gene was performed using the dRhodamine terminator cycle sequencing kit (Perkin-Elmer Corp., Norwalk, CT, USA) and analysed by an automated sequencer (Applied Biosystems, Foster City, CA, USA). Both the forward and reverse strands were sequenced and mutations detected were con®rmed by repeated sequencing from an independent PCR reaction. The primer sequences were as described previously (Yuen et al., 1997) . (d) Ampli®cation of the EGFR gene was detected by the dierential PCR method with the cystic ®brosis (CF) gene as a reference, similar to the method described previously (Hunter et al., 1995; Tohma et al., 1998) . After PCR and gel electrophoresis, the intensity of the EGFR fragment (110 bp) and CF reference fragment (79 bp) were measured by the GDS8000 Complete Gel Documentation and Analysis system (UV Products, Cambridge, UK). The mean EGFR/CF ratios using DNA from peripheral blood of healthy adults was 1.41 with a standard deviation of 0.17. The threshold value of EGFR/CF ratio above 3.22 was regarded as evidence of EGFR ampli®cation. The three MSI-H glioblastomas (lanes A, B, C) and normal blood leukocytes (lane N) had a ratio of 1.4 while a glioblastoma with known EGFR ampli®cation (lane G) has a ratio of 8.6
quality to permit p53 sequencing. In contrast to the glial tumours, all three metachronous colorectal carcinomas did not overexpress p53 protein. Direct DNA sequencing performed in two colorectal carcinomas con®rmed the absence of mutation in the p53 gene.
In view of the reported association of EGFR ampli®cation with some sporadic glial tumours, we studied all three glioblastomas and two colorectal carcinomas for ampli®cation of this gene, using dierential PCR, with the cystic ®brosis (CF) gene as reference (Hunter et al., 1995; Tohma et al., 1998) . EGFR ampli®cation was absent from all the tumours.
To identify chromosomal aberrations in these tumours, we performed comparative genomic hybridization (CGH) (Figure 2) (Kallioniemi et al., 1992) , together with propidium iodide¯ow cytometry for estimation of DNA index. Numerous gains and losses of chromosomal arms were identi®ed in the glioblastoma of patient C, which showed a grossly aneuploid DNA index of 1.7. The glioblastomas of patients D and A were near tetraploid, but still showed proportional loss of several chromosome arms. All three glioblastomas showed deletion of 9p, a change known to be common in sporadic glioblastomas Mohapatra et al., 1995; Nishizaki et al., 1998; Schlegel et al., 1996; Weber et al., 1996) . This common deletion involves 9p21 where the CDKN2A gene, coding for p16, an inhibitor of cyclin dependent kinases, is situated. Sporadic glioblastomas arising de novo often show gain of 7p corresponding to EGFR ampli®cation, but this was absent in all three cases. One glioblastoma showed 10q loss, including the region 10q 23.3 where the PTEN gene is located. We also found loss of 12p in two of the three glioblastomas, a change seldom observed in sporadic glioblastoma.
Of the two colorectal carcinomas examined, both showed 13q ampli®cation, a very common chromosomal abnormality in sporadic colorectal carcinoma (Ried et al., 1996) . One colorectal carcinoma showed no other chromosomal gain or loss, which, together with a diploid DNA content, is consistent with overall chromosomal stability as usually observed in MS1-H colorectal carcinomas (Schlegel et al., 1995) . The colorectal carcinoma of patient B also showed a pattern consistent with that observed in sporadic colorectal tumours with mismatch repair de®ciency, with a near-diploid DNA index (1.08) and only a small number of chromosomal gains and losses identi®ed by CGH.
Our results suggest that inactivation of p53 is essential for glioblastoma development even in the presence of a defective mismatch repair pathway. Figure 2 Summary of copy number aberrations (CNAs) observed by comparative genomic hybridization in three MSI-H glioblastomas and two MSI-H colorectal carcinomas. Lines to the left of each chromosome ideogram show regions of reduced relative DNA copy number, and lines to the right show regions of increased relative DNA copy number. Each line represents a CNA found in one tumour. Tumour DNA extracted from frozen tissue was labelled with biotin-16-dUTP (Boehringer Mannheim, Mannheim, Germany) and reference normal placental DNA with digoxigenin-11-dUTP (Boehringer Mannheim) using a two-stage degenerate oligonucleotide primed-polymerase chain reaction (DOP ± PCR). The probe fragment sizes were between 500 bp to 2000 bp after labelling. Five hundred ng of each labelled DNA were co-hybridized to denatured normal metaphase CGH target slides (Vysis UK, Ltd., Surrey, UK) in the presence of 5 ug of Cot-1 DNA (Boehringer Mannheim) for 3 days at 378C, washed and the immuno¯uorescence detection was performed in a single layer using a mixture of Avidin Cy3 and anti-digoxigenin FITC conjugated Fab fragments (Boehringer Mannheim). Slides were counterstained with mountant containing DAPI (VectaShield containing DAPI, Vector). Hybridization images were captured using SmartCapture VP acquisition software from a Zeiss Axioplan II¯uorescence microscope (Carl Zeiss Ltd., Welwyn Garden City, UK) equipped with a SenSys charged coupled device (CCD) camera (Photometrics, Tucson, AZ, USA) and ®lter set for detection of Cy3, FITC and DAPI. The images were analysed by Quantitative Image Processing System (QUIPS) software (Vysis Ltd, Surrey, UK). At least 10 metaphase spreads were analysed from each slide. Because sex chromosomes might be under dierent selection pressure in tumours derived from males and females, they were not analysed. Thresholds, following standardization in a series of control hybridizations, were set to 1.2 and 0.8 for scoring chromosomal gains and losses Interestingly, in four further glioblastomas with microsatellite instability, described by others, p53 mutation was also present (Cheng et al., 1999; Gafanovich et al., 1999; Miyaki et al., 1997) . This is in sharp contrast to colorectal carcinoma arising in conditions of mismatch repair de®ciency, where numerous studies have shown a low incidence of p53 mutation (Cottu et al., 1996; Ionov et al., 1993; Konishi et al., 1996; Olschwang et al., 1997) . Absence of mutation in TGFbRII gene and presence of p53 mutation in MSI-H glioblastomas, and the reverse in the MSI-H colorectal carcinomas support the conclusion that carcinogenic pathways are organ-speci®c, even when activated in cells with a similar basic mismatch repair defect.
Data from sporadic glioblastomas suggest two patterns of development, distinguished by the relative frequency of EGFR ampli®cation and p53 mutation (Kleihues and Ohgaki, 1997; Lang et al., 1994; von Deimling et al., 1993 von Deimling et al., , 1995 Watanabe et al., 1996) . Secondary glioblastomas arise (usually in younger patients) through progression from a lower grade astrocytoma; in these, around two-thirds show mutation in p53 but EGFR ampli®cation is exceedingly rare. Primary glioblastomas arise de novo, without preceding lower grade astrocytoma, tend to occur in older patients, and in up to 50% have EGFR ampli®cation without p53 mutation. The characteristic molecular genetic constellation and the young age of onset of the three MSI-H glioblastomas described here is thus closer to that of typical secondary glioblastomas, although we had no evidence for a pre-existing tumour in these patients. The absence of a pre-existing lower grade tumour could result from an accelerated oncogenic process, analogous to the accelerated adenoma-carcinoma sequence of HNPCC colorectal tumours.
Patients with colorectal carcinoma, coincident with germ-line mutation in mismatch repair genes, tend to develop near-diploid cancers with few chromosomal aberrations, often without p53 mutation, and this is the pattern observed here Bocker et al., 1996; Cottu et al., 1996; Feeley et al., 1999; Forster et al., 1998; Ionov et al., 1993; Konishi et al., 1996; Lothe et al., 1993; Olschwang et al., 1997; Remvikos et al., 1995; Schlegel et al., 1995) . Previous studies have suggested that loss of p53 function is associated with chromosomal instability, favouring the development of aneuploidy, polyploidy, chromosomal breaks and ampli®cation (Bischo et al., 1990; Bouer et al., 1995; Carder et al., 1993; Donehower et al., 1995; Fukasawa et al., 1997; Harvey et al., 1993; Livingstone et al., 1992; Meling et al., 1993; Purdie et al., 1994; Tsukada et al., 1993; Yin et al., 1992) . However, studies in a series of colorectal carcinoma cell lines by others, and sporadic colorectal cancers by us, suggest that, even in the presence of p53 mutation, MSI-H tumours remain chromosomal stable and near-diploid, rather than developing the multiple errors in chromosome number and structure shown typically by sporadic colorectal tumours without microsatellite instability (Eshleman et al., 1998; Curtis et al., 2000) . In contrast, we have shown that MSI-H glioblastomas typically develop chromosomal instability and aneuploidy accompanying p53 mutation. The unexpected coexistence of microsatellite instability and chromosomal instability phenotype in these glioblastomas suggests a complicated relationship between MSI, p53 mutation and chromosomal instability. As p53 mutation does not invariably induce chromosomal instability, there may be other mechanisms that suppress chromosomal instability, which remain intact in MSI colorectal carcinomas but are defective in MSI glioblastomas. Moreover, the dierential pattern of chromosomal aberration, with presence of 9p deletion in all glioblastomas but not in colorectal carcinomas, again, suggests selective targeting of organ-speci®c pathways by the chromosomal instability.
Thus, in summary, in this small series of patients with germ-line mutation in mismatch repair genes, we demonstrate divergent, organ-speci®c pathways of tumour development. Whilst colorectal cancers in these patients tend to remain near-diploid and show the phenotype associated with HNPCC, the development of the glioblastomas follows a pattern similar to that of so-called secondary sporadic glioblastomas, with p53 inactivation and aneuploidy. The results appear to suggest that, following loss of mismatch repair function, p53 inactivation and chromosome instability are not necessary for development of malignant colorectal tumours, but are required for genesis of glioblastoma.
